Myocardial energy metabolism in ischemic preconditioning and cardioplegia: A metabolic control analysis

Molecular and Cellular Biochemistry

Volumn 278, Issue 1-2, 2005, Pages 223-232

  Vogt, Achim M ^a   Elsässer, Albrecht ^c   Pott Beckert, Anja ^a   Ackermann, Cordula ^a   Vetter, Sven Y ^a   Yildiz, Murat ^a   Schoels, Wolfgang ^a   Fell, David A ^b   Katus, Hugo A ^a   Kübler, Wolfgang ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Cardioplegia; Energy metabolism; High energy phosphates; Infarct size; Ischemic preconditioning; Myocardial protection

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; COMPUTER SIMULATION; CONTROLLED STUDY; ENERGY METABOLISM; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEART PROTECTION; METABOLIC REGULATION; NONHUMAN; SWINE;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HEART ARREST, INDUCED; ISCHEMIC PRECONDITIONING; KINETICS; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHATES; PHOSPHOCREATINE; SWINE;

EID: 26444561493     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-7576-x     Document Type: Article

References (27)

1. Reimer K: The slowing of ischemic energy demand in preconditioned myocardium. Ann N Y Acad Sci 793: 13-26, 1996 8906152
2. Kübler W: Tierexperimentelle Untersuchungen zum Myokardstoff-wechsel im Angina-pectoris-Anfall und beim Herzinfarkt. S. Karger, Basel, 1969
3. Fell D: Understanding the control of metabolism, Portland Press, London, 1997
4. Vogt A, Ando H, Arras M, Elsässer A: Lacking adenosine causes myocardial refractoriness. J Am Coll Cardiol 31: 1134-1141, 1998 10.1016/ S0735-1097(98)00061-8
5. Kupriyanov V, St Jean M, Xiang B, Butler K, Deslauriers R: Contractile dysfunction caused by normothermic ischaemia and KCl arrest in the isolated pig heart: A 31-P NMR study. J Mol Cell Cardiol 27: 1715-1730, 1995 10.1016/S0022-2828(95)90854-4
6. Schott R, Rohmann S, Braun E, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1133-1142, 1990 2317890
7. Sellevold O, Jynge P, Aarstad K: High performance liquid chromatography: A rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 18: 517-527, 1986 3723598
8. Vogt AM, Ackermann C, Noe T, Jensen D, Kübler W: Simultaneous detection of high energy phosphates and metabolites of glycolysis and the Krebs cycle by HPLC. Biochem Biophys Res Commun 248: 527-532, 1998 9703959
9. Brand M: Control of oxidative phosphorylation in liver mitochondria and cells: Top-down (C)control (A)nalysis and top-down (E)lasticity (A)nalysis. In: P. Hochacka, P. Lutz, T. Sick, M. Rosenthal, G. van den Thillart (eds). Surviving Hypoxia: Mechanisms of Control and Adaptation. CRC Press, Boca Raton, FL, 1993, pp 295-309
10. Brand M: Top-down elasticity analysis and its application ti energy metabolism in isolated mitochondria and intact cells. Mol Cell Biochem 184: 13-20, 1998 10.1023/A:1006893619101
11. Sauro H: SCAMP: A general purpose simulator and metabolic control analysis program. Comput Appl Biosci 9: 441-450, 1993 8402211
12. Kübler W, Spieckermann P: Regulation of glycolysis in the ischemic and anoxic myocardium. J Mol Cell Cardiol 1: 351-377, 1970 10.1016/ 0022-2828(70)90034-9
13. Reimer K, Jennings R: Myocadial ischemia, hypoxia, and infarction. In: H. Fozzard, E. Haber, R. Jennings, A. Katz, H. Morgan (eds). The Heart and Cardiovascular System: Scientific Foundations, 2nd edn. Raven Press, New York, 1992, pp 1875-1973
14. Kober IM, Obermayr RP, Brull T, Ehsani N, Schneider B, Spieckermann PG: Comparison of the solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest. Eur Surg Res 30: 243-251, 1998 10.1159/ 000008583
15. Schnabel PA, Gebhard MM, Pomykaj T, Schmiedl A, Preusse CJ, Richter J, Bretschneider HJ: Myocardial protection: Left ventricular ultrastructure after different forms of cardiac arrest. Thorac Cardiovasc Surg 35: 148-156, 1987
16. Mitchell MB, Winter CB, Locke Winter CR, Banerjee A, Harken AH: Cardiac preconditioning does not require myocardial stunning. Ann Thorac Surg 55: 395-400, 1993
17. Gross G, Fryer R: Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 84: 973-979, 1999
18. Grover G, Newburger J, Sleph P, Dzwonczyk S, Taylor S, Ahmed S, Atwal K: Cardioprotective effects of the potassium channel opener cromakalim: Stereoselectivity and effects of myocardial adenine nucleotides. J Pharmacol Exp Ther 257: 156-162, 1991
19. McPherson P, Pierce G, Cole W: Ischemic cardioprotection by ATP-sensitive K+-channels involves high-energy phosphate preservation. Am J Physiol 265: H1809-1818, 1993
20. Wikström B, Ronquist G, Waldenström A: Glyburide enhancement of lactate production in ischemic heart is modified by ischemic preconditioning: An in vivo experimental study in pigs by michodialysis technique. J Cardiovasc Pharmacol 27: 622-628, 1996 10.1097/ 00005344-199605000-00002
21. Kolocassides K, Seymour A, Galinanes M, Hearse D: Paradixical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in rat heart. J Mol Cell Cardiol 28: 1045-1057, 1996 10.1006/jmcc.1996.0097
22. Illes RW, Wright JK, Inners McBride K, Yang CJ, Tristan A: Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg 58: 1481-1485, 1994 7979679
23. Lu EX, Chen SX, Hu TH, Xui LM, Yuan MD: Preconditioning enhances myocardial protection in patients undergoing open heart surgery. Thorac Cardiovasc Surg 46: 28-32, 1998 9554045
24. Kolocassides KG, Galinanes M, Hearse DJ: Dichotomy of ischemic preconditioning: Improved postischemic contractile function despite intensification of ischemic contracture. Circulation 93: 1725-1733, 1996 8653879
25. Kemp GJ, Manners DN, Clark JF, Bastin ME, Radda GK: Theoretical modelling of some spatial and temporal aspects of the mitochondrion/ creatine kinase/myofibril system in muscle. Mol Cell Biochem 184: 249-289, 1998 10.1023/A:1006848726795
26. Golding E, Teague W, Dobson G: Adjustment of K′ to varying pH and pMg for the creatine kinase, adenylate kinase and ATP hydrolysis equilibria permitting quantitative bioenergetic assessment. J Exp Biol 198: 1775-1782, 1995 7636446
27. Soboll S, Conrad A, Hebisch S: Influence of mitochondrial creatine kinase on the mitochondrial/extramitochondrial distribution of high energy phosphates in muscle tissue: Evidence for a leak in the creatine shuttle. Mol Cell Biochem 133/134: 105-113, 1994